Boosting defence R&D and attracting more top companies to participate are among possible future growth opportunities identified in a pathfinder prepared for the high level group that is scoping the EU’s 2021 –2028 research programme
CLORA has called for a strengthened and impactful FP9 and European Research Area (ERA). They argue for fostering excellence and greater collaboration. They also call for FP9 to be more accessible to citizens — through outreach — and to researchers through simplification and improved success rates
“Whenever you hear environmental expert, think urban eco imperialist,” said Myron Ebell, speaking in Brussels. But his Trumpian message met stiff protests.
Danish pharmaceutical firm says it will invest £115M over the next decade in the latest signal that for now the UK’s advantages in discovery research in life sciences are outweighing concerns about Brexit
The peremptory announcement that the UK will withdraw from the EU Atomic Energy Community risks a talent drain and leaves unanswered questions over funding for nuclear science and the future of the Joint European Torus
Will research fare better if Scotland remains part of the UK, or does Brexit mean academics should change their spots and vote for an independent country if there is another referendum? Science|Business tests the mood
Research will support the modernisation and independence of Europe’s arms manufacturers, but the sensitive nature of the work means there will not be the usual oversight and scrutiny of the programme by experts or MEPs
The European Commission announced the names of 15 well-known business people who will form a new High Level Group of Innovators to advise on innovation policy. This is the list.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.